Table 2.
Quantitative assessment of myocardial mass, scar mass, and LGE extent
| 2D-LGE | 3D-LGE | Bias ± SD | r | |
|---|---|---|---|---|
| CMI | ||||
| Global myocardial mass (g) | 87.3 ± 24.1 | 94.9 ± 26.1 | – 7.6 ± 11.7 (p < 0.01) | 0.93 (p < 0.01) |
| Global scar mass (g) | 10.3 ± 8.7 | 11.1 ± 9.5 | – 0.8 ± 3.2 (p = 0.06) | 0.94 (p < 0.01) |
| Global LGE extent (%) | 11.4 ± 7.5 | 11.5 ± 8.5 | – 0.1 ± 3.2 (p = 0.99) | 0.93 (p < 0.01) |
| MYC | ||||
| Global myocardial mass (g) | 64.7 ± 14.7 | 70.2 ± 18.9 | – 5.4 ± 7.7 (p < 0.05) | 0.92 (p < 0.01) |
| Global scar mass (g) | 18.1 ± 12.2 | 19.0 ± 11.6 | – 0.9 ± 4.4 (p = 0.40) | 0.93 (p < 0.01) |
| Global LGE extent (%) | 27.0 ± 15.7 | 26.2 ± 13.1 | 0.8 ± 6.7 (p = 0.70) | 0.91 (p < 0.01) |
CMI chronic myocardial infarction, MYC Myocarditis, LGE late gadolinium enhancement, r Pearson correlation coefficient between 2D-LGE and 3D-LGE